cognitive cybersecurity intelligence

News and Analysis

Invitae to Appeal Trial Verdict

SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States District Court for the District of Delaware. The jury found that Invitae’s products using Anchored…

Source: www.marketscreener.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

NCSC Issues Warning as UK Sees Four Cyber Attacks a Week

British organisations are facing an unprecedented cyber security crisis as the National Cyber Security Centre reveals a dramatic surge in attacks threatening the nation’s digital

Windows Remote Access Connection Manager 0-Day Vulnerability Actively Exploited in Attacks

Microsoft has confirmed active exploitation of a critical zero-day vulnerability in the Windows Remote Access Connection Manager (RasMan) service, allowing attackers to escalate privileges and

The 8 Most Dangerous File Types for Malware Infections – Security Boulevard

The 8 Most Dangerous File Types for Malware Infections Security Boulevard

Leukemia Progression Mapped by New Multi-Omics Tool, GoT-Multi

Cancer doesn’t follow a linear path—it evolves, adapts, and forks. Even within a single tumor, individual cells behave differently. They mutate, diverge, and form heterogeneous

News and Analysis

Invitae to Appeal Trial Verdict

Subscribe to newsletter

More Posts

NCSC Issues Warning as UK Sees Four Cyber Attacks a Week

Windows Remote Access Connection Manager 0-Day Vulnerability Actively Exploited in Attacks

The 8 Most Dangerous File Types for Malware Infections – Security Boulevard

Leukemia Progression Mapped by New Multi-Omics Tool, GoT-Multi

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company